[1] Researchers report that the peptide exhibited equivalent or better performance using two recombinant CHO cell lines. IGF-1 LR3 may be more capable of inducing the type 1 IGF receptor, potentially promoting an elevated level of intracellular signaling, cellular proliferation, and apoptosis inhibition
For those seeking more subtle, sustained benefits, microdosing CJC-1295 has emerged as a refined strategy
This study revealed that NPI-001 (NACA), NPI-002 (diNACA) and NAC exhibited varying degrees of antioxidant activity, i.e., protected cultured rat retinal cells from a variety of stressors which were designed to mimic aspects of the pathology of different retinal diseases
For subcutaneous administration, 250-500 mcg per day represents the standard range, with some protocols using 300 mcg as a target dose
If you decline, we wont track your data, except for a single cookie to remember your choice